BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1107261 HOUSTON, TX

Position in LENZ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$255,600

-$123,396 QoQ

Shares Held

45,000

+105.3% QoQ

Ownership

0.143%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 143 holders

Holding Since

Sep 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. LENZ ranks #72 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$255,600	45,000	+105.3%	Shares	Sole	2026-08-14
2024-06-30	$378,996	21,920	0.0%	Shares	Sole	2024-08-14
2024-03-31	$489,473	21,920	—	Shares	Sole	2024-05-15
2023-12-31 GRPH	—	172,750	0.0%	Shares	Sole	2024-02-14
2023-09-30 GRPH	—	172,750	+32.5%	Shares	Sole	2023-11-14
2023-06-30 GRPH	—	130,350	-1.1%	Shares	Sole	2023-08-14
2023-03-31 GRPH	—	131,800	+1.0%	Shares	Sole	2023-05-15
2022-12-31 GRPH	—	130,500	+15.0%	Shares	Sole	2023-02-14
2022-09-30 GRPH	—	113,500	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.